All Companies
Ticker RLMD
Below our coverage size floor
You reached the page — here's exactly what RLMD is, and why it's out of scope for now.
What this ticker is
RLMD
Relmada Therapeutics Inc.
NASDAQ
Healthcare
Biotechnology
United States
Mkt cap $466.1M
Relmada Therapeutics Inc. is a clinical-stage biotechnology company focused on developing therapies for oncology and central nervous system disorders. Its current pipeline centers on product candidates designed to address areas of significant unmet medical need, including NDV-01 for non-muscle invasive bladder cancer and sepranolone for neurological and com…
Why we can't analyze it yet
Below business size floor — market cap $466,147,227 is under our $500,000,000 coverage minimum
Delvantic analyzes regular securities of single operating companies — one business with revenue, earnings and cash flows our valuation methods can assess bottom-up.
Reason code:
below_coverage